Laurion Capital Management’s Lyra Therapeutics LYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-14,957
Closed -$4.65M 514
2024
Q1
$4.65M Buy
14,957
+14,109
+1,664% +$4.39M 0.04% 129
2023
Q4
$222K Buy
+848
New +$222K ﹤0.01% 214